FY24/FY25 ffrdc leases operational task order
Ended Awarded Last action
- Contract number
- 75N91024F00027
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $27,031,348
Award facts
- Opportunity
-
- NCIOSFM240114 Solicitation number
- Contract value 100% obligated
-
- $27,031,348.00 Current, with exercised options
- $27,116,766.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$2,372 | |
| Funding Only Action | $490,482 | |
| Funding Only Action | $4,486,987 | |
| Funding Only Action | $763,435 | |
| Original award | $21,292,816 |
About this award
The National Cancer Institute issued a delivery order to Leidos Biomedical Research Inc. on August 31, 2024, with a ceiling value of $27,116,766 for FY24/FY25 FFRDC leases operational support.
This is a delivery order under the National Cancer Institute's indefinite delivery contract with Leidos Biomedical Research Inc., the FFRDC contractor providing comprehensive biomedical research and facilities support services. Place of performance is Frederick, MD. The order is priced on a cost-plus-fixed-fee basis with an ultimate completion date of August 30, 2025.
In FY2024, the order invoked $1 thousand in government-paid labor across 19 contractor hours at a derived rate of $73.91 per hour. Leidos Biomedical Research Inc. self-performed all reported hours with no subcontractor engagement in that fiscal year.
Quick answers
Who was awarded contract 75N91024F00027?
75N91024F00027 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2024.
How much is contract 75N91024F00027 worth?
The government has obligated $27,031,348 on 75N91024F00027. Its potential value, with all options, is $27,116,766.
Is contract 75N91024F00027 an order under another contract?
Yes. 75N91024F00027 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91024F00027 competed?
The extent of competition for 75N91024F00027 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award